AI Longevity Daily

Today’s Summary

Overexpression of a single regulatory protein extended lifespan in aged mice, with no signs of tumor risk in cell experiments.
A pig kidney stored at ultra-low temperature for a year still produced urine after transplant — the first successful validation on a human-sized organ.
The lifespan extension results haven't been replicated in humans yet, and whether they can translate into human therapies remains uncertain.

🔥 Today’s Top 10 Hottest Picks

1. Splicing Factor SRSF1 Extends Lifespan in Aged Mice by 14%

SRSF1, the splicing factor that ultimately won out, was identified after researchers ran a machine learning scan across gene expression profiles of human skin cells at different ages — hunting for candidates that could dial back “transcriptomic age” (how old a cell looks based on its gene expression patterns). Splicing factors are regulatory proteins that can simultaneously influence how thousands of genes are read, so tweaking one is essentially flipping multiple aging switches at once. In cell experiments, SRSF1 overexpression cut down on cellular senescence, protein buildup, and chronic inflammation — and crucially, cells didn’t lose their original identity. That last part is the exact problem that’s haunted Yamanaka factors (another rejuvenation approach, but one that carries tumor risk) for years. When SRSF1 was delivered into aged mice, lifespan stretched by 14%. These results are mouse-only for now, and whether they’ll hold up in humans is still an open question — check out Fight Aging!’s report for more on the screening methodology and cell phenotype details.

2. Pig Kidney Stored at -150°C for a Year Transplanted Successfully and Produced Urine 🧊

This experiment started by perfusing pig kidney vasculature with iron oxide nanoparticles, then vitrification-freezing (a deep-cryopreservation method that avoids ice crystal damage) the organ down to -150°C for up to a year. On retrieval, an alternating electromagnetic field caused the nanoparticles to generate heat uniformly from the inside out — elegantly solving the uneven rewarming problem that plagues large organs (surface vs. deep tissue heating at different rates). Post-thaw, the kidneys maintained vascular, metabolic, and excretory function during ex vivo perfusion, produced urine immediately after transplant, and recovered function close to the traditional cold-storage control group. This technique had previously only been validated on small rodent kidneys, making this the first successful demonstration on a human-sized organ — a real step toward long-term organ banking. One catch: nanoparticles have to be injected before freezing, so it won’t work on already-preserved tissue. See Fight Aging!’s report for rewarming protocol details.

3. Lysosomal Metabolite Buildup Can Predict Cell Age — Caloric Restriction Helps Everywhere Except the Brain 🧠

Lysosomes, the cell’s “recycling centers” responsible for breaking down old proteins and structures, got a closer look when researchers isolated them from multiple species and tissue types for metabolomic and lipidomic analysis. Three metabolite classes consistently accumulate in lysosomes with age: glycerophosphodiesters (GPD), cystine, and a membrane lipid called BMP. This accumulation pattern is conserved across species and can be used to predict a cell’s chronological age — essentially a “lysosomal clock.” Caloric restriction (eating less) slows these changes in peripheral tissues, but it doesn’t work in the brain. And the cells where accumulation is most pronounced? Neurons and microglia — the very cells at the center of neurodegenerative disease. Whether these metabolites are just aging markers or are actively accelerating aging is still up in the air. Head to Fight Aging!’s report for the analysis methods and cross-species data.

4. A Natural Anti-Amyloid Peptide Found in Blood — Alzheimer’s Patients Have Lower Levels

HAEE, a synthetic peptide originally designed to block amyloid-β (Aβ, the protein that abnormally aggregates in Alzheimer’s brains) from binding zinc ions — and thus prevent Aβ clumping — turned out to have a surprising origin story. While researchers were building a blood detection method ahead of clinical trials, they stumbled onto the fact that HAEE is actually a natural component of human blood plasma. Further comparison of samples from 200 Alzheimer’s patients against 150 cognitively normal controls showed significantly lower endogenous HAEE concentrations in patient plasma. This hints that low HAEE might be a diagnostic marker, and it puts synthetic HAEE supplementation on the table as a candidate therapy — but we’re still in observational territory here, and causality plus clinical efficacy need trial data to back them up. Check Fight Aging!’s report for detection methodology and sample details.

5. The Gut-Bone Connection: Aging Gut Microbiome Disrupts Bone Balance Through the Immune System 🦴

This review lays out how gut microbiome aging (dysbiosis) accelerates bone loss via the bone marrow immune microenvironment. Bone is in constant remodeling — osteoblasts building it up, osteoclasts tearing it down — and an imbalance between the two is the direct cause of osteoporosis. An aging gut microbiome worsens intestinal barrier leakage, letting inflammatory signals spill into the bloodstream and reach the bone marrow, where they activate more osteoclasts. On top of that, the aging microbiome may also influence bone marrow immune cell behavior through the vagus and sympathetic nerves. This framework pushes osteoporosis etiology beyond “local bone degeneration” into a gut-nerve-immune-bone whole-system model — though the relative importance of each pathway is still debated. See Fight Aging!’s report for the specific mechanisms covered in the review.

6. Cold Stress Longevity Mechanism: Muscle-Produced BH2 Crosses Tissues to Protect Proteins 🥶

Mild cold temperatures extend lifespan across multiple species, but the mechanism has been murky. Researchers found in C. elegans that cold elevates synthesis of a metabolite called BH2 in muscle tissue. BH2 can travel from muscle to intestine and neurons, where it converts into active cofactor BH4, which then helps cells synthesize tyrosine and suppress protein aggregation (abnormal protein clumping being a hallmark of Huntington’s, ALS, and other neurodegenerative diseases). Boosting BH2 synthesis in muscle alone extended worm lifespan at normal temperatures and reduced protein aggregation in distant tissues. In human cell experiments, supplementing BH2 or tyrosine also reduced aggregation of proteins linked to Huntington’s and ALS. Most results are worm- and cell-based so far, and independent human validation is still needed. See Fight Aging!’s report for the cross-species experimental design.

7. Cancer Can Be Driven by Epigenetic Changes Alone — No DNA Mutations Required

The standard story is that cancer comes from DNA mutations, but YAP1, a transcriptional co-activator, rewrites that narrative. In a mouse liver cancer model, researchers found that activating YAP1 caused liver cells to switch on multiple oncogenes through DNA demethylation (an epigenetic change — altering which gene “switches” are on or off, not the sequence itself) — with no typical driver gene mutations showing up in whole-exome sequencing. Knocking down Tet1, a gene that promotes demethylation, significantly reduced liver tumor formation. The same molecular signature was found in liver samples from patients with a congenital heart defect associated with liver cancer. The upshot: epigenetic disruption accumulated during aging may itself be a cancer driver, not just a bystander to DNA mutations. The mechanisms are mostly from mouse experiments so far — see Fight Aging!’s report for single-cell spatial transcriptomics results.

8. MicroRNA miR-3155b Found to Suppress Inflammatory Signaling in Senescent Cells 🔥

Senescent cells don’t die — they just keep pumping out pro-inflammatory signals to everything around them. That’s SASP (senescence-associated secretory phenotype), a major driver of tissue aging and post-cancer-treatment side effects. In a chemotherapy-induced senescence model using breast cancer cells, miR-3155b, a small RNA, was found to be significantly downregulated during senescence. Artificially raising its levels suppressed expression of multiple pro-inflammatory factors including IL-6, IL-8, and TNF — while the senescent state itself (division arrest, DNA damage markers) stayed unchanged. In other words, it dials down the flames without disbanding the old cells. This is a senomorphic strategy (modulating senescent cells) rather than a senolytic one (clearing them out). Results are cell-only for now — see Fight Aging!’s report for target validation details.

9. A Hidden Risk in Stem Cell Therapy: “Toxic Exosomes” Generated During Cell Culture ⚠️

During in vitro expansion, some stem cells enter a senescent state and start releasing exosomes (nanoscale vesicles cells use to communicate with each other) loaded with misfolded proteins — particularly oxidatively damaged SOD1 protein. These “toxic exosomes” can trigger cascading senescence in recipient cells, a phenomenon already documented in neural stem cell line experiments. The paper calls for making senescent cell percentage and exosome proteome integrity standard quality control metrics in stem cell manufacturing — though neither is currently a regulatory requirement. Similar risks in mesenchymal stem cell and iPSC-derived products still await independent validation. See Fight Aging!’s report for the specific QC proposals.

10. Alzheimer’s May Be a Whole-Body Amyloid Imbalance — and the Liver Is Key 🧬

Alzheimer’s has long been framed as a brain-local problem, but this review pulls together emerging evidence that tells a different story. Brain amyloid-β (Aβ) and blood Aβ exist in dynamic equilibrium — clearing Aβ from the blood side can actually pull brain Aβ outward. The review systematically covers four brain drainage pathways (including the blood-brain barrier and glymphatic system) along with peripheral clearance via the liver, kidneys, and gut. The liver comes out as the primary organ for peripheral Aβ elimination, and the core cause of brain Aβ deposition isn’t a single failed pathway — it’s the collapse of multiple pathways working in concert. See Fight Aging!’s report for details on each clearance pathway and combination therapy ideas. This framework is still in the theoretical and early trial stage.

⌘ Open Source Top Projects

agnikitha/retfound-cvd-screening: Estimating Cardiovascular Risk and Retinal Biological Age from Fundus Images 👁️

This project is built on RETFound (a vision foundation model pretrained specifically on retinal images) and puts together an AI platform that simultaneously handles cardiovascular risk-related metrics (carotid intima-media thickness CIMT, a marker for arterial stiffness), retinal biological age estimation, and five disease classifications. Retinal vasculature is essentially a natural window into the body’s vascular health, and RETFound captures image features correlated with systemic health status through large-scale fundus image pretraining. The repo description lists non-invasive screening as the use case — but correlation between image features and these metrics doesn’t equal accurate measurement of specific test values. Actual precision and applicable populations require checking the evaluation results inside the repo. Repo: agnikitha/retfound-cvd-screening , last active late October 2026.

🧪 Cutting-Edge Research

“Immature” Astrocytes in the Brain Correlate with Cognitive Decline

Using hippocampal tissue surgically removed from epilepsy patients, researchers found that a class of “immature astrocytes” marked by Dcx+ increases with age — and their numbers correlate with the degree of fluid intelligence decline (a cognitive metric measuring the ability to quickly learn and solve novel problems). Astrocytes are typically thought of as support cells for neurons, but a growing body of evidence shows they actively participate in regulating learning and memory. The big caveat here: samples came from epilepsy patients, whose brains age faster than average. Whether the correlation holds for the general population is uncertain, and the mechanisms need follow-up research. See Fight Aging!’s report for cognitive assessment methods and cell count data.